THE DEFENDER:French Researchers Identify ‘Improbably High Rate of Deaths’ in Newborns Who Received New RSV Shot
Independent French researchers discovered a significant increase in newborn deaths in France coinciding with the rollout of Beyfortus, a new respiratory syncytial virus shot for infants.
French researchers identified possible safety signals in babies coinciding with the rollout of Beyfortus, a recently approved monoclonal antibody treatment for respiratory syncytial virus (RSV) in newborns.
The discovery comes as public health authorities ramp up warnings about the spread of respiratory viruses and step up their promotion of the drug.
In interviews with The Defender, the researchers — French independent scientist and author Hélène Banoun, Ph.D., and French statistician Christine Mackoi — explained that data from France’s National Institute of Statistics and Economic Studies (INSEE) indicates an improbably high rate of deaths of babies between 2 and 6 days old in France during September and October 2023.
READ ON AT THE DEFENDER…
We will never know how safe it is until we star administering it.
Sounds familiar?
Pardon my French, but SSDD.
That said, though the evil continues, I remain optimistic that more people are continuing to wake up to it.